Search Results - "Tawbi, Hussain"

Development of an Educational Website for Patients With Cancer and Preexisting Autoimmune Diseases Considering Immune Checkpoint Blockers: Usability and Acceptability Study by Lopez-Olivo, Maria A, Suarez-Almazor, Maria E, Duhon, Gabrielle F, Cherry, McKenna, Lu, Huifang, Calabrese, Cassandra, Altan, Mehmet, Tawbi, Hussain, Meara, Alexa, Bingham, Clifton O, Diab, Adi, Leal, Viola B, Volk, Robert J

“…Patients with cancer and an underlying autoimmune disease who are considering immune checkpoint blockers (ICBs) need to know about the benefits and risks of…”
Get full text

910 Development and user testing of a website with information for cancer patients who have pre-existing autoimmune disease and are considering immune checkpoint inhibitors (ICIs) by Lopez-Olivo, Maria A, Suarez-Almazor, Maria E, Duhon, Gabrielle F, Erck, McKenna, Calabrese, Cassandra, Altan, Mehmet, Tawbi, Hussain, Meara, Alexa, Bingham, Clifton, Diab, Adi, Leal, Viola B, Volk, Robert J

“…BackgroundPatients considering ICIs for their cancer who also have an underlying autoimmune disease need to be informed about the potential for flares of the…”
Get full text

444 Unveiling immune-related adverse events (irAEs) and symptom burden in melanoma patients on adjuvant immune checkpoint inhibitors (ICIs) by Abdel-Wahab, Noha, Anouti, Bilal, Abdel-Wahab, Reham, Gonzales, Zaida, Spillson, Christine A, Baum, George P, Bentebibel, Salah-Eddine, Manzano, Joanna-Grace M, McQuade, Jennifer, Glitza, Isabella, Amaria, Rodabe, Patel, Sapna, Wong, Michael K, Tawbi, Hussain, Davies, Michael A, Ekmekcioglu, Suhendan, Tweardy, David, Sharma, Padmanee, Shete, Sanjay, Peterson, Susan, Yee, Cassian, Suarez-Almazor, Maria E, Diab, Adi

“…BackgroundAdjuvant ICIs are approved for melanoma, but challenges persist regarding irAEs and their long-term impact on quality of life (QOL). Existing data…”
Get full text

Melanoma central nervous system metastases: current approaches, challenges, and opportunities by Cohen, Justine V., Tawbi, Hussain, Margolin, Kim A., Amravadi, Ravi, Bosenberg, Marcus, Brastianos, Priscilla K., Chiang, Veronica L., de Groot, John, Glitza, Isabella C., Herlyn, Meenhard, Holmen, Sheri L., Jilaveanu, Lucia B., Lassman, Andrew, Moschos, Stergios, Postow, Michael A., Thomas, Reena, Tsiouris, John A., Wen, Patrick, White, Richard M., Turnham, Timothy, Davies, Michael A., Kluger, Harriet M.

“…Summary Melanoma central nervous system metastases are increasing, and the challenges presented by this patient population remain complex. In December 2015,…”
Get full text

Abstract LB-B30: First in human, dose escalation trial of the combination of dabrafenib, trametinib, and navitoclax in patients with BRAF mutant solid tumors by Sullivan, Ryan J., Mehnert, Janice, Tawbi, Hussain, Lawrence, Donald, Flaherty, Keith, Chen, Helen, Takabe, Naoko, Davies, Michael

“…Combined BRAF and MEK inhibitor therapy is associated with responses in patients (pts) with BRAF mutant solid tumors. Preclinically, the addition of the BH3…”
Get full text

Abstract 5788: Single-cell and spatial transcriptomic mapping of human renal cell carcinoma brain metastases uncovers actionable immune-resistance targets by Hasanov, Elshad, Lam, Truong Nguyen Anh, Lin, Jerome, Reville, Patrick K., Hasanov, Merve, Casasent, Anna K., Shih, David, Hanalioglu, Sahin, Bilen, Mehmet Asim, Alhalabi, Omar, Babaoglu, Berrin, Baylarov, Baylar, Osunkoya, Adeboye O., Norberg, Lisa M., Gumin, Joy, Tran, Tuan M., Li, Jianzhuo, Hoang, Anh G., Chancoco, Haidee D., Kerrigan, Brittany C. Parker, Thompson, Erika J., Kim, Betty YS, Suki, Dima, Mut, Melike, Soylemezoglu, Figen, Genovese, Giannicola, Akdemir, Kadir C., Tawbi, Hussain A., Tannir, Nizar M., McAllister, Florencia, Davies, Michael A., Sharma, Padmanee, Huse, Jason, Lang, Frederick, Navin, Nicholas, Jonasch, Eric

“…Introduction: The discovery of immune checkpoint inhibitors has revolutionized metastatic renal cell carcinoma (RCC) treatment. However, in patients with RCC…”
Get full text